What type of diseases does cell and gene therapy treat?

The cell and gene therapy treats a variety of diseases including adenosine deaminase severe combined immunodeficiency (ADA- SCID), congenital blindness, hemophilia, Lebers congenital amaurosis, lysosomal storage diseases, X-linked chronic granulomatous disease, etc.

What is the difference between cell and gene therapy?

Cell therapy involves the transfer of cells with desired function into the patient, whereas gene therapy involves the transfer of genetic material in a carrier or vector and the uptake of the gene into targeted cells.

What are the references?

Food and Drug Administration, Government of Canada, Press Information Bureau, Department of Biotechnology, Government of India.

Cell And Gene Therapy Manufacturing Market leads 16.25% CAGR by 2034

Content

Executive Summary Introduction Market Dynamics Market Segmentation Market's Cross Sectional Segmentations Competitive Landscape Market Trends and Opportunities Supply Chain Analysis Regulatory Landscape Case Studies Future Outlook Appendix

Executive Summary

Market Overview
Key Findings
Market Size and Growth Projections
- Market Value
- Market Volume
Key Market Trends
Competitive Landscape Summary

Introduction

Market Definition
Research Methodology
Scope of the Report
Assumptions and Limitations

Market Dynamics

Market Drivers
- Advances in Cell and Gene Therapy Technologies
- Increasing Incidence of Chronic Diseases
- Rising Investments in Cell and Gene Therapy Research
Market Restraints
- High Cost of Therapy Development
- Regulatory Challenges
Market Opportunities
- Emerging Markets
- Technological Innovations
Market Challenges
- Manufacturing Complexities
- Supply Chain Issues

Market Segmentation

By Therapy Type
- Allogeneic Cell Therapy
- Autologous Cell Therapy
By Technology Type
- Somatic Cell Technology
- Cell Immortalization Technology
- Viral Vector Technology
- Genome Editing Technology
- Cell Plasticity Technology
- 3D Technology
By Source
- Umbilical Cord
- Neural Stem
- Bone Marrow
- Adipose Tissue
- IPSC's (Induced Pluripotent Stem Cell)
By Application
- Musculoskeletal
- Cardiovascular
- Gastrointestinal
- Neurological
- Oncology
- Dermatology
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa

Market's Cross Sectional Segmentations

By Therapy Type

Allogeneic Cell Therapy
- Market Value: Revenue generated from manufacturing and commercializing allogeneic cell therapies.
- Market Volume: Quantity of allogeneic cell therapies produced and administered.
- Cross-Segmentation Analysis:
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
Autologous Cell Therapy
- Market Value: Revenue from autologous cell therapies.
- Market Volume: Quantity of autologous cell therapies produced and used.
- Cross-Segmentation Analysis:
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa

By Technology Type

Somatic Cell Technology
- Market Value: Revenue from the use of somatic cell technology in cell and gene therapy manufacturing.
- Market Volume: Quantity of therapies using somatic cell technology.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
Cell Immortalization Technology
- Market Value: Revenue from cell immortalization technology.
- Market Volume: Quantity of therapies using cell immortalization technology.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
    - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
Viral Vector Technology
- Market Value: Revenue from viral vector technology.
- Market Volume: Quantity of therapies utilizing viral vector technology.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
Genome Editing Technology
- Market Value: Revenue from genome editing technologies.
- Market Volume: Quantity of therapies using genome editing technologies.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
Cell Plasticity Technology
- Market Value: Revenue from cell plasticity technologies.
- Market Volume: Quantity of therapies using cell plasticity technologies.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
3D Technology
- Market Value: Revenue from 3D technologies in cell and gene therapy.
- Market Volume: Quantity of therapies developed using 3D technologies.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa

By Source

Umbilical Cord
- Market Value: Revenue from therapies using umbilical cord-derived cells.
- Market Volume: Quantity of umbilical cord-derived therapies.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
Neural Stem
- Market Value: Revenue from neural stem cell therapies.
- Market Volume: Quantity of neural stem cell therapies.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
Bone Marrow
- Market Value: Revenue from bone marrow-derived cell therapies.
- Market Volume: Quantity of bone marrow-derived therapies.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
Adipose Tissue
- Market Value: Revenue from adipose tissue-derived cell therapies.
- Market Volume: Quantity of adipose tissue-derived therapies.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
IPSCs (Induced Pluripotent Stem Cells)
- Market Value: Revenue from IPSCs-based therapies.
- Market Volume: Quantity of IPSCs-based therapies.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa

By Application

Musculoskeletal
- Market Value: Revenue from musculoskeletal application therapies.
- Market Volume: Quantity of therapies for musculoskeletal applications.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
Cardiovascular
- Market Value: Revenue from cardiovascular application therapies.
- Market Volume: Quantity of therapies for cardiovascular applications.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
Gastrointestinal
- Market Value: Revenue from gastrointestinal application therapies.
- Market Volume: Quantity of therapies for gastrointestinal applications.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
Neurological
- Market Value: Revenue from neurological application therapies.
- Market Volume: Quantity of therapies for neurological applications.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
Oncology
- Market Value: Revenue from oncology application therapies.
- Market Volume: Quantity of therapies for oncology applications.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - - Allogeneic Cell Therapy
      - Autologous Cell Therapy
    - By Technology Type:
      - Somatic Cell Technology
      - Cell Immortalization Technology
      - Viral Vector Technology
      - Genome Editing Technology
      - Cell Plasticity Technology
      - 3D Technology
    - By Source:
      - Umbilical Cord
      - Neural Stem
      - Bone Marrow
      - Adipose Tissue
      - IPSCs (Induced Pluripotent Stem Cells)
    - By Region:
      - North America
      - Europe
      - Asia Pacific
      - Latin America
      - Middle East
      - Africa
Dermatology
- Market Value: Revenue from dermatology application therapies.
- Market Volume: Quantity of therapies for dermatology applications.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
Others
- Market Value: Revenue from other application areas not specified above.
- Market Volume: Quantity of therapies for other applications.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Region:
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa

By Region

North America
- Market Value: Total revenue from cell and gene therapy manufacturing in North America.
- Market Volume: Quantity of therapies produced and administered in North America.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
Europe
- Market Value: Total revenue from cell and gene therapy manufacturing in Europe.
- Market Volume: Quantity of therapies produced and administered in Europe.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
Asia Pacific
- Market Value: Total revenue from cell and gene therapy manufacturing in Asia Pacific.
- Market Volume: Quantity of therapies produced and administered in Asia Pacific.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
Latin America
- Market Value: Total revenue from cell and gene therapy manufacturing in Latin America.
- Market Volume: Quantity of therapies produced and administered in Latin America.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
Middle East
- Market Value: Total revenue from cell and gene therapy manufacturing in the Middle East.
- Market Volume: Quantity of therapies produced and administered in the Middle East.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others
Africa
- Market Value: Total revenue from cell and gene therapy manufacturing in Africa.
- Market Volume: Quantity of therapies produced and administered in Africa.
- Cross-Segmentation Analysis:
  - By Therapy Type:
    - Allogeneic Cell Therapy
    - Autologous Cell Therapy
  - By Technology Type:
    - Somatic Cell Technology
    - Cell Immortalization Technology
    - Viral Vector Technology
    - Genome Editing Technology
    - Cell Plasticity Technology
    - 3D Technology
  - By Source:
    - Umbilical Cord
    - Neural Stem
    - Bone Marrow
    - Adipose Tissue
    - IPSCs (Induced Pluripotent Stem Cells)
  - By Application:
    - Musculoskeletal
    - Cardiovascular
    - Gastrointestinal
    - Neurological
    - Oncology
    - Dermatology
    - Others

Competitive Landscape

Market Share Analysis
Key Player Profiles
Bluebird Bio Inc.
- Overview
- Financial Performance
- Product Portfolio
- Recent Developments
- Strategies
Hitachi Chemical Co., Ltd.
Takara Bio Inc.
Catalent Inc.
F. Hoffmann-La Roche Ltd.
Samsung Biologics
Novartis AG
Lonza
Merck KGaA
Wuxi Advanced Therapies
Boehringer Ingelheim
Cellular Therapeutics
Miltenyi Biotec
Thermo Fisher Scientific
F. Hoffmann-La Roche Ltd
Bluebird Bio Inc.
Competitive Benchmarking

Market Trends and Opportunities

Technological Advancements in Manufacturing
Collaborations and Partnerships
Expanding Pipeline of Cell and Gene Therapies
Regulatory Approvals and Updates

Supply Chain Analysis

Raw Material Suppliers
Manufacturing Process
Distribution Channels
End-User Analysis

Regulatory Landscape

Overview of Regulatory Bodies
Key Regulations and Guidelines
Impact of Regulations on Market Growth

Case Studies

Successful Cell and Gene Therapy Manufacturing Projects
Challenges and Solutions in Manufacturing

Future Outlook

Market Forecast
- Forecast by Therapy Type
- Forecast by Technology Type
- Forecast by Source
- Forecast by Application
- Forecast by Region
Emerging Trends
Strategic Recommendations for Stakeholders

Appendix

List of Abbreviations
Glossary of Terms
Research Methodology
References
Contact Information

Insight Code: 5024
No. of Pages: 150
Format: PDF/PPT/Excel
Published: May 2025
Report Covered: [Revenue + Volume]
Historical Year: 2021-2022
Base Year: 2023
Estimated Years: 2024-2033